Key facts
- It has raised $35.0M; the latest was Debt - General in Jul 2025.
- Notable investors include Echo Health Ventures, Pittco Management, Noro-Moseley Partners, Pittco Direct Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Medix Infusion
- ·The full record, as it builds
Funding rounds
No funding rounds for Medix Infusion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medix Infusion
Provider of specialty pharmacy services intended to offer convenient, and customized infusion therapy. The company's services include providing personalized home and in-suite infusion therapy services for chronic or acute conditions to treat illnesses of high-acuity patients with infusion & injectable mediums, enabling patients in rural, suburban, and other under-served markets to get physician-prescribed medical therapies.
- Sector
- Healthcare
- HQ
- Addison, TX, United States
- Founded
- 2020
- Employees
- 104
- Website
- medixinfusion.com/
- Ownership
- Privately Held (backing)
Medix Infusion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medix Infusion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medix Infusion in its N-PORT filings yet. We sweep new filings monthly.